Similar to its role in COPD, the irisin-BDNF signaling pathway contributes to attenuation of mood disorders, including anxiety and depression, in asthma patients (Szilasi et al., 2017). This evidence concerns the gene FNDC5 and chronic obstructive pulmonary disease.